Alberta Investment Management Corp Makes New Investment in Zoetis Inc. $ZTS

Alberta Investment Management Corp purchased a new stake in Zoetis Inc. (NYSE:ZTS) in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 37,100 shares of the company’s stock, valued at approximately $5,428,000.

Other institutional investors have also made changes to their positions in the company. Savvy Advisors Inc. lifted its holdings in Zoetis by 54.0% during the second quarter. Savvy Advisors Inc. now owns 3,177 shares of the company’s stock worth $495,000 after acquiring an additional 1,114 shares during the period. CIBC Asset Management Inc grew its stake in Zoetis by 4.3% in the 3rd quarter. CIBC Asset Management Inc now owns 251,495 shares of the company’s stock valued at $36,745,000 after purchasing an additional 10,434 shares during the period. Chicago Partners Investment Group LLC boosted its holdings in shares of Zoetis by 67.0% in the 2nd quarter. Chicago Partners Investment Group LLC now owns 4,886 shares of the company’s stock worth $750,000 after buying an additional 1,961 shares during the last quarter. Mitsubishi UFJ Trust & Banking Corp boosted its holdings in shares of Zoetis by 6.5% in the 3rd quarter. Mitsubishi UFJ Trust & Banking Corp now owns 295,482 shares of the company’s stock worth $43,235,000 after buying an additional 18,040 shares during the last quarter. Finally, Ninety One UK Ltd grew its position in Zoetis by 19.6% during the third quarter. Ninety One UK Ltd now owns 1,119,132 shares of the company’s stock valued at $163,751,000 after buying an additional 183,686 shares during the period. 92.80% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of research analysts have recently weighed in on ZTS shares. UBS Group set a $136.00 target price on shares of Zoetis in a research report on Thursday, January 29th. Piper Sandler reiterated a “neutral” rating and issued a $135.00 price objective (down previously from $190.00) on shares of Zoetis in a research note on Thursday, January 22nd. KeyCorp assumed coverage on Zoetis in a research report on Thursday, November 20th. They issued a “sector weight” rating for the company. Morgan Stanley set a $160.00 price target on Zoetis in a research report on Thursday, December 18th. Finally, The Goldman Sachs Group upgraded Zoetis to a “buy” rating in a research note on Monday, December 15th. Five analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, Zoetis currently has an average rating of “Hold” and a consensus target price of $152.91.

Zoetis Price Performance

Zoetis stock opened at $129.17 on Thursday. The business has a 50-day simple moving average of $125.01 and a 200 day simple moving average of $135.02. Zoetis Inc. has a 52 week low of $115.25 and a 52 week high of $177.00. The stock has a market cap of $54.53 billion, a price-to-earnings ratio of 21.46, a PEG ratio of 1.92 and a beta of 0.96. The company has a quick ratio of 1.94, a current ratio of 3.03 and a debt-to-equity ratio of 2.71.

Zoetis (NYSE:ZTS) last posted its quarterly earnings data on Thursday, February 12th. The company reported $1.48 earnings per share for the quarter, topping the consensus estimate of $1.40 by $0.08. The company had revenue of $2.39 billion for the quarter, compared to analysts’ expectations of $2.36 billion. Zoetis had a net margin of 28.24% and a return on equity of 62.02%. Zoetis’s revenue for the quarter was up 3.0% compared to the same quarter last year. During the same period in the prior year, the business earned $1.40 earnings per share. Zoetis has set its FY 2026 guidance at 7.000-7.100 EPS. On average, research analysts forecast that Zoetis Inc. will post 6.07 earnings per share for the current fiscal year.

Zoetis Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 2nd. Investors of record on Monday, April 20th will be paid a $0.53 dividend. This represents a $2.12 annualized dividend and a dividend yield of 1.6%. The ex-dividend date of this dividend is Monday, April 20th. Zoetis’s payout ratio is presently 35.22%.

Zoetis Company Profile

Zoetis Inc (NYSE: ZTS) is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company’s offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.